FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295009434> ?p ?o ?g. }

• W4295009434 endingPage "110140" @default.
• W4295009434 startingPage "110140" @default.
• W4295009434 abstract "Phytochemicals with bone formation potential in traditional medicines captured more and more attentions due to their advantages to bone loss and fewer side effects. As a famous aphrodisiac phytomedicine, Eurycoma longifolia (EL) has acquired general recognition in improving male sexual health, and thus been considered as traditional medicine for the treatment of androgen-deficient osteoporosis. Although the aqueous extract of EL had been proved to be beneficial to bone loss, the active constituents and the mechanisms underlying the effects are still obscure. The current study performed a chemical investigation on the roots of EL, which resulted in the isolation and identification of ten quassinoids (EL-1-EL-10), and then conducted their osteogenic activity evaluations in vivo zebrafish model with or without dexamethasone (Dex) and in vitro C3H10 cell model. The result displayed that most tested concentrations of EL-1-EL-5 could significantly increase the mineralization areas and integrated optical densities (IODs) of skull in both zebrafish model. The majority tested concentrations of EL-1-EL-5 could also improve the mRNA expression of early osteogenic associated genes ALPL, Runx2a, Sp7 in zebrafish model without Dex, but only a few could accelerate the mRNA expression of late osteogenic associated genes OCN. These results suggested the ability of EL-1-EL-5 to increase bone formation mainly by accelerating osteogenic differentiation at the early stage. The structure-based virtual screening based on the pharmacophores in ePharmaLib, as well as the molecular docking study, implied that the effects of the quassinoids (EL-1-EL-5) on the enhancement of bone formation might be related with improving the content and the activity of androgen through binding with CYP19A, SHBG and AKR1C2, and activating bone metabolism-related ANDR target genes and signal pathways by combining with ANDR directly. Although the assumptions are in silico model-based and further in vitro and in vivo validations are still necessary, we provided a new perspective to explore the potential of EL to be used as an alternative treatment for not only androgen-deficient osteoporosis, but also estrogen-deficient bone loss, by combining with SHBG." @default.
• W4295009434 created "2022-09-09" @default.
• W4295009434 creator A5007870731 @default.
• W4295009434 creator A5011322673 @default.
• W4295009434 creator A5015861344 @default.
• W4295009434 creator A5027170454 @default.
• W4295009434 creator A5029982064 @default.
• W4295009434 creator A5037525829 @default.
• W4295009434 creator A5057233052 @default.
• W4295009434 creator A5059128927 @default.
• W4295009434 creator A5074692938 @default.
• W4295009434 creator A5076958401 @default.
• W4295009434 date "2022-11-01" @default.
• W4295009434 modified "2023-09-30" @default.
• W4295009434 title "Quassinoids from Eurycoma longifolia and their bone formation evaluation in zebrafish, C3H10 cells and silico" @default.
• W4295009434 cites W1544030891 @default.
• W4295009434 cites W1968077233 @default.
• W4295009434 cites W1971010166 @default.
• W4295009434 cites W1979045528 @default.
• W4295009434 cites W1979185801 @default.
• W4295009434 cites W1985779452 @default.
• W4295009434 cites W1993163303 @default.
• W4295009434 cites W2004270193 @default.
• W4295009434 cites W2016971364 @default.
• W4295009434 cites W2036850077 @default.
• W4295009434 cites W2051589737 @default.
• W4295009434 cites W2056470289 @default.
• W4295009434 cites W2063093883 @default.
• W4295009434 cites W2090003718 @default.
• W4295009434 cites W2093513059 @default.
• W4295009434 cites W2125072209 @default.
• W4295009434 cites W2137663488 @default.
• W4295009434 cites W2145255535 @default.
• W4295009434 cites W2151281431 @default.
• W4295009434 cites W2183050958 @default.
• W4295009434 cites W2524169823 @default.
• W4295009434 cites W2606113946 @default.
• W4295009434 cites W2735579573 @default.
• W4295009434 cites W2770318103 @default.
• W4295009434 cites W2787856597 @default.
• W4295009434 cites W2802186612 @default.
• W4295009434 cites W2809382108 @default.
• W4295009434 cites W2840139243 @default.
• W4295009434 cites W2885279741 @default.
• W4295009434 cites W294715574 @default.
• W4295009434 cites W2991213176 @default.
• W4295009434 cites W2995446227 @default.
• W4295009434 cites W3009074681 @default.
• W4295009434 cites W3013665133 @default.
• W4295009434 cites W3092298388 @default.
• W4295009434 cites W3130205963 @default.
• W4295009434 cites W3181362870 @default.
• W4295009434 doi "https://doi.org/10.1016/j.cbi.2022.110140" @default.
• W4295009434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36087817" @default.
• W4295009434 hasPublicationYear "2022" @default.
• W4295009434 type Work @default.
• W4295009434 citedByCount "2" @default.
• W4295009434 countsByYear W42950094342022 @default.
• W4295009434 countsByYear W42950094342023 @default.
• W4295009434 crossrefType "journal-article" @default.
• W4295009434 hasAuthorship W4295009434A5007870731 @default.
• W4295009434 hasAuthorship W4295009434A5011322673 @default.
• W4295009434 hasAuthorship W4295009434A5015861344 @default.
• W4295009434 hasAuthorship W4295009434A5027170454 @default.
• W4295009434 hasAuthorship W4295009434A5029982064 @default.
• W4295009434 hasAuthorship W4295009434A5037525829 @default.
• W4295009434 hasAuthorship W4295009434A5057233052 @default.
• W4295009434 hasAuthorship W4295009434A5059128927 @default.
• W4295009434 hasAuthorship W4295009434A5074692938 @default.
• W4295009434 hasAuthorship W4295009434A5076958401 @default.
• W4295009434 hasConcept C104317684 @default.
• W4295009434 hasConcept C150903083 @default.
• W4295009434 hasConcept C185592680 @default.
• W4295009434 hasConcept C207001950 @default.
• W4295009434 hasConcept C2775905019 @default.
• W4295009434 hasConcept C2776878037 @default.
• W4295009434 hasConcept C55493867 @default.
• W4295009434 hasConcept C86803240 @default.
• W4295009434 hasConcept C98274493 @default.
• W4295009434 hasConceptScore W4295009434C104317684 @default.
• W4295009434 hasConceptScore W4295009434C150903083 @default.
• W4295009434 hasConceptScore W4295009434C185592680 @default.
• W4295009434 hasConceptScore W4295009434C207001950 @default.
• W4295009434 hasConceptScore W4295009434C2775905019 @default.
• W4295009434 hasConceptScore W4295009434C2776878037 @default.
• W4295009434 hasConceptScore W4295009434C55493867 @default.
• W4295009434 hasConceptScore W4295009434C86803240 @default.
• W4295009434 hasConceptScore W4295009434C98274493 @default.
• W4295009434 hasLocation W42950094341 @default.
• W4295009434 hasLocation W42950094342 @default.
• W4295009434 hasOpenAccess W4295009434 @default.
• W4295009434 hasPrimaryLocation W42950094341 @default.
• W4295009434 hasRelatedWork W2003750019 @default.
• W4295009434 hasRelatedWork W2067185634 @default.
• W4295009434 hasRelatedWork W2095111365 @default.
• W4295009434 hasRelatedWork W2317214312 @default.
• W4295009434 hasRelatedWork W2333605542 @default.
• W4295009434 hasRelatedWork W2599067145 @default.

• next